Outcome related electrophysiological subtypes of cocaine dependence.
- Authors
- Prichep, Leslie S; Alper, Kenneth R; Sverdlov, Lev; Kowalik, Sharon C; John, E R; Merkin, Henry; Tom, Mee Lee; Howard, Bryant; Rosenthal, Mitchell S
- Year
- 2002
- Journal
- Clinical EEG (electroencephalography)
- PMID
- 11795212
- DOI
- 10.1177/155005940203300104
We previously described the existence of two quantitative EEG (QEEG) subtypes of cocaine dependent males, identified at baseline, displaying differential proneness to relapse. The current study expands the population to include females and enhances the measure set to include both QEEG and somatosensory EP (SEP) features. Fifty-seven cocaine dependent adults (16 F, 41 M) were evaluated 5-14 days after last cocaine use, while in residence at a drug-free therapeutic community. The median length of stay in treatment (continued abstinence) was 25 weeks. Using a small subset of QEEG and SEP baseline features, three subtypes (CLUS) were identified. CLUS 2 (n = 25) and CLUS 3 (n = 23) replicated the published subtypes, while CLUS 1 (n = 9) was previously undescribed. Cluster membership was significantly associated with length of stay in treatment (chi 2 = 13.789, P < 0.001), but not with length of exposure to crack cocaine or to any demographic or clinical features. Seventy-eight percent of CLUS 1 and 65% of CLUS 3 left treatment < or = 25 weeks, whereas 80% of CLUS 2 remained in treatment > 25 weeks. The existence of outcome related subtypes may reflect: [1] differential neurophysiological vulnerability, "traits," predisposing individuals to cocaine addiction; or [2] differential neurosensitivity, "states," due to the effects of chronic cocaine exposure, and associated differences in treatment outcome. Using Variable Resolution Electrical Tomographic Analysis (VARETA), the mathematically most probable neuroanatomical source of the scalp recorded EEG data was localized. Computation of VARETA on the baseline Cluster profiles suggest significant differences in the underlying pathophysiology of these subtypes.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| A scoping review of electroencephalographic (EEG) markers for tracking neurophysiological changes and predicting outcomes in substance use disorder treatment. | Bel-Bahar TS et al. | — | 2022 | → |
| Neuromarkers for Mental Disorders: Harnessing Population Neuroscience. | Jollans L et al. | — | 2018 | → |
| Advances in Electrophysiological Research. | Kamarajan C et al. | — | 2015 | → |
| Quantitative EEG and neurofeedback in children and adolescents: anxiety disorders, depressive disorders, comorbid addiction and attention-deficit/hyperactivity disorder, and brain injury. | Simkin DR et al. | — | 2014 | → |
| Quantitative Electroencephalography Analysis (qEEG) of Neuro-Electro-Adaptive Therapy 12™ [NEAT12] Up-Regulates Cortical Potentials in an Alcoholic during Protracted Abstinence: Putative Anti-Craving Implications. | Waite RL et al. | — | 2014 | → |
| Quantitative EEG in hospital encephalopathy: review and microstate analysis. | Sarkis RA et al. | — | 2013 | → |
| Reliability of quantitative EEG (qEEG) measures and LORETA current source density at 30 days. | Cannon RL et al. | — | 2012 | → |
| Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports. | Miller DK et al. | — | 2010 | → |
| Neurofeedback Effects on Evoked and Induced EEG Gamma Band Reactivity to Drug-related Cues in Cocaine Addiction. | Horrell T et al. | — | 2010 | → |
| Recent EEG and ERP findings in substance abusers. | Ceballos NA et al. | — | 2009 | → |
| EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research. | Sokhadze TM et al. | — | 2008 | → |
| EEG absolute power during extended cocaine abstinence. | Levin KH et al. | — | 2007 | → |
| Electrophysiological subtypes of psychotic states. | John ER et al. | — | 2007 | → |
| Biological research on drug abuse and addiction in Hispanics: current status and future directions. | Trujillo KA et al. | — | 2006 | → |
| Clinical correlates of quantitative EEG alterations in alcoholic patients. | Coutin-Churchman P et al. | — | 2006 | → |
| EEG topography and tomography (LORETA) in the classification and evaluation of the pharmacodynamics of psychotropic drugs. | Saletu B et al. | — | 2006 | → |
| Will future forensic assessment be neurobiologic? | Popma A et al. | — | 2006 | → |
| The role of quantitative electroencephalography in child and adolescent psychiatric disorders. | Chabot RJ et al. | — | 2005 | → |
| Use of normative databases and statistical methods in demonstrating clinical utility of QEEG: importance and cautions. | Prichep LS | — | 2005 | → |
| Biological markers of cocaine addiction: implications for medications development. | Elkashef A et al. | — | 2003 | → |
| Quantitative spectral analysis of EEG in psychiatry revisited: drawing signs out of numbers in a clinical setting. | Coutin-Churchman P et al. | — | 2003 | → |